ロード中...
Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment
Background: Fatigue is a common complaint in patients with idiopathic pulmonary fibrosis (IPF) and has been reported in a considerable percentage of patients. Fatigue is also a registered side effect of pirfenidone, one of two approved antifibrotic drugs. The Fatigue Assessment Scale (FAS) was devel...
保存先:
| 出版年: | Eur Clin Respir J |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7717873/ https://ncbi.nlm.nih.gov/pubmed/33312458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20018525.2020.1853658 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|